Loading...
BioLargo, Inc.
BLGO•PNK
Basic Materials
Chemicals
$0.18
$0.001(0.47%)
BioLargo, Inc. (BLGO) Financial Performance & Income Statement Overview
Review BioLargo, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
45.37%
↑ 45.37%
Operating Income Growth
-3.46%
↓ 3.46%
Net Income Growth
31.45%
↑ 31.45%
Operating Cash Flow Growth
-35.56%
↓ 35.56%
Operating Margin
-33.33%
↓ 33.33%
Gross Margin
43.56%
↑ 43.56%
Net Profit Margin
-19.32%
↓ 19.32%
ROE
-40.56%
↓ 40.56%
ROIC
-76.06%
↓ 76.06%
BioLargo, Inc. (BLGO) Income Statement & Financial Overview
Review BioLargo, Inc.'s (BLGO) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.66M | $4.35M | $5.01M | $4.76M |
| Cost of Revenue | $1.91M | $2.63M | $2.88M | $2.51M |
| Gross Profit | $1.75M | $1.72M | $2.14M | $2.25M |
| Gross Profit Ratio | $0.48 | $0.40 | $0.43 | $0.47 |
| R&D Expenses | $784000.00 | $690000.00 | $623000.00 | $784000.00 |
| SG&A Expenses | $2.58M | $2.09M | $2.40M | $2.23M |
| Operating Expenses | $3.37M | $2.78M | $3.03M | $3.009M |
| Total Costs & Expenses | $5.27M | $5.41M | $5.90M | $5.52M |
| Interest Income | $0.00 | $1000.00 | $0.00 | $0.00 |
| Interest Expense | $127000.00 | $0.00 | $2000.00 | $12000.00 |
| Depreciation & Amortization | $67000.00 | $68000.00 | $38000.00 | $36000.00 |
| EBITDA | -$1.64M | -$993000.00 | -$740000.00 | -$727000.00 |
| EBITDA Ratio | -$0.45 | -$0.23 | -$0.15 | -$0.15 |
| Operating Income | -$1.62M | -$1.06M | -$890000.00 | -$763000.00 |
| Operating Income Ratio | -$0.44 | -$0.24 | -$0.18 | -$0.16 |
| Other Income/Expenses (Net) | -$116000.00 | $524000.00 | $110000.00 | -$12000.00 |
| Income Before Tax | -$1.73M | -$537000.00 | -$780000.00 | -$775000.00 |
| Income Before Tax Ratio | -$0.47 | -$0.12 | -$0.16 | -$0.16 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$365000.00 |
| Net Income | -$1.01M | -$537000.00 | -$441000.00 | -$410000.00 |
| Net Income Ratio | -$0.28 | -$0.12 | -$0.09 | -$0.09 |
| EPS | -$0.003 | -$0.002 | -$0.002 | -$0.001 |
| Diluted EPS | -$0.003 | -$0.002 | -$0.002 | -$0.001 |
| Weighted Avg Shares Outstanding | $298.12M | $300.49M | $296.44M | $294.31M |
| Weighted Avg Shares Outstanding (Diluted) | $298.12M | $300.49M | $296.44M | $294.31M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan